Market movers: UnitedHealth Group, GE Aerospace, RTX Corporation, Lucid Group…

The article is dominated by earnings beats and upbeat corporate updates: RTX reported Q1 EPS of $1.78 versus about $1.52 expected, GE Aerospace posted EPS of $1.86 and revenue of $11.61 billion versus $1.60 and $10.71 billion expected, and UnitedHealth lifted 2026 adjusted EPS guidance to more than $18.25 from more than $17.75. Halliburton and D.R. Horton also beat estimates, while Lucid jumped 10.3% after Uber agreed to invest an additional $200 million. The most price-sensitive individual catalysts are the higher guidance from UnitedHealth and the better-than-expected results from RTX and GE Aerospace.

Analysis

The cleanest read-through is that the market is rewarding balance-sheet resilience and pricing power over pure top-line growth. UNH and GE are the highest-quality signals here: both are effectively telling the market that cost inflation is being absorbed better than feared, which tends to compress risk premia across managed care and aerospace suppliers rather than just lift the individual names. That matters for second-order positioning because it supports a rotation into “self-help plus visibility” compounders while leaving lower-quality cyclicals vulnerable if investors conclude margin durability matters more than nominal growth.

RTX’s beat is more important than the headline suggests because defense exposure is now increasingly being re-rated through the lens of backlog conversion and aftermarket mix, not just defense spending growth. If commercial engines and services are accelerating this fast, the broader aerospace supply chain should see tighter lead times and firmer pricing power into 2H26, which is positive for tier-two suppliers but also raises the bar for airlines and OEMs on costs. The risk is that the market extrapolates one quarter into a straight-line recovery; any hiccup in engine shop visits, delivery cadence, or export timing would hit sentiment quickly over the next 1-2 quarters.

LCID remains a financing narrative masquerading as a product narrative. Uber’s incremental capital is supportive near term, but the real implication is that strategic investors are being used as a bridge to extend runway and optionality; that often inflates the equity for days, not months, unless unit economics visibly improve. The contrarian angle is that the market may be overpricing takeover speculation while underpricing dilution risk and the likelihood that any eventual strategic solution happens at a discount to today’s price.

UNH is the most actionable fundamental surprise because medical cost control can re-rate the whole managed-care cohort if peers confirm similar trend moderation. Conversely, if this is idiosyncratic rather than industry-wide, the rally will fade as investors refocus on utilization normalization later in the year. That makes the next earnings cycle the critical catalyst window: the trade is less about one quarter and more about whether 2026 margin fears are structurally too high.

Key Decisions for Investors

• Long UNH versus short IHF for the next 4-8 weeks: express a view that managed-care margin discipline is underappreciated, with upside if peers validate improving cost trends; cover if utilization commentary turns adverse.
• Buy RTX on pullbacks for a 1-3 month trade: the beat supports higher backlog conversion multiples, but size modestly because any supply-chain or delivery miss could reverse the move quickly.
• Pair long GE / short a basket of industrials with weaker margin visibility over the next quarter: GE’s mix shift and service leverage should outperform if the market continues to reward execution over cyclicality.
• Avoid chasing LCID above the immediate headline move; if expressing upside, use limited-risk call spreads only after the next capital-markets disclosure, since dilution/financing risk remains the dominant medium-term variable.
• Relative-value long aerospace suppliers versus airlines for 2H26 positioning: stronger engine and services economics favor the supply chain, while airlines remain exposed to cost pass-through pressure.